<DOC>
	<DOC>NCT00123903</DOC>
	<brief_summary>This study was designed to determine whether COREG MR is more effective than TOPROL-XL in reducing microalbuminuria in type 2 diabetic or non-diabetic patients with high blood pressure and microalbuminuria.</brief_summary>
	<brief_title>COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Albuminuria</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<criteria>Inclusion criteria: Documented history of hypertension. Must have been taking an ACE (angiotensin converting enzyme) inhibitor either alone or as part of an antihypertensive regimen for at least 8 weeks. Persistent microalbuminuria. Exclusion criteria: History of heart attack, stroke, congestive heart failure, arrhythmia, type 1 or uncontrolled type 2 diabetes mellitus, liver or renal disease. Has been taking any nonocular betablockers for any indication within three months prior to Prescreening.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>hypertension</keyword>
	<keyword>urine albumin:creatinine ratio</keyword>
	<keyword>microalbuminuria</keyword>
</DOC>